Arctic Bioscience – Mandatory notification of trade
Ronja Capital AS, a legal person closely associated with a person discharging managerial responsibility in Arctic Bioscience, has today transferred 3,087,999 shares in Arctic Bioscience to Ronja Capital Investment AS at an average price of NOK 13,50 per share. Both companies are controlled by Roger Halsebakk and closely related to board member Tore Tønseth in Arctic Bioscience AS.After the transaction Ronja Capital AS holds 0 shares and Ronja Capital Investment AS holds 3,087,999 shares in Arctic Bioscience AS, corresponding to an ownership of 12.17 % of the issued and outstanding share